NKE
Buy and Hold Forever? Here's How Nike and Lululemon Athletica Stack Up
Nike and Lululemon Athletica have established brands, but is that enough to warrant a forever place in your portfolio?
Motley Fool  ·  Apr 25, 2026 READ →
LULU
Buy and Hold Forever? Here's How Nike and Lululemon Athletica Stack Up
Nike and Lululemon Athletica have established brands, but is that enough to warrant a forever place in your portfolio?
Motley Fool  ·  Apr 25, 2026 READ →
JNJ
How The Johnson & Johnson (JNJ) Investment Story Is Shifting As Analysts Rework Targets
Analysts have lifted the fair value estimate for Johnson & Johnson from US$241.71 to US$252.42, while price targets across recent research now span from around US$250 up to US$280. That shift reflects ongoing debate about how much growth key drugs like Tremfya and late stage assets can support, with some firms leaning more optimistic and others staying Neutral even as they raise targets. As you read on, you will see how to interpret these moves and track the evolving story around Johnson &...
Simply Wall St.  ·  Apr 25, 2026 READ →
BMY
Pfizer Tests Transparent Eliquis Pricing As Valuation Signals Undervaluation
Pfizer (NYSE:PFE) and Bristol Myers Squibb are making their blood thinner Eliquis available through the Mark Cuban Cost Plus Drug Company platform. The move brings a blockbuster prescription medicine into a lower cost, direct to consumer channel aimed at greater price transparency. This collaboration focuses on expanding patient access to Eliquis while testing alternative distribution and pricing approaches for high demand drugs. For investors following NYSE:PFE, this development sits at...
Simply Wall St.  ·  Apr 25, 2026 READ →
PFE
Pfizer Tests Transparent Eliquis Pricing As Valuation Signals Undervaluation
Pfizer (NYSE:PFE) and Bristol Myers Squibb are making their blood thinner Eliquis available through the Mark Cuban Cost Plus Drug Company platform. The move brings a blockbuster prescription medicine into a lower cost, direct to consumer channel aimed at greater price transparency. This collaboration focuses on expanding patient access to Eliquis while testing alternative distribution and pricing approaches for high demand drugs. For investors following NYSE:PFE, this development sits at...
Simply Wall St.  ·  Apr 25, 2026 READ →
GOOGL
Alphabet’s US$40b Anthropic Bet Tests AI Capex And Cloud Economics
Alphabet announces plans to invest up to $40b in Anthropic, deepening their AI partnership. As part of the deal, Anthropic will use Google Cloud as its primary AI infrastructure provider. The agreement includes long term commitments around cloud capacity and access to Alphabet’s TPU chips. Alphabet, listed as NasdaqGS:GOOGL, is tying this large AI commitment to a share price of $344.4. The stock has returned 18.4% over the past 30 days and 9.3% year to date, with a 1 year return of 113.4%...
Simply Wall St.  ·  Apr 25, 2026 READ →
AMZN
Why Amazon (AMZN) Stock Is Trading Up Today
Shares of cloud computing and online retail behemoth Amazon (NASDAQ:AMZN) jumped 3.5% in the afternoon session after Meta struck a multi-billion dollar deal with its Amazon Web Services (AWS) division and multiple analysts raised their price targets on the stock.
StockStory  ·  Apr 25, 2026 READ →
AVGO
Trump disclosures show $51M+ invested in bonds in March
Investing.com -- Disclosures released by the US Office of Government Ethics on Saturday reveal that U.S. President Donald Trump carried out a total of 175 transactions in March, purchasing at least $51 million in bonds across several sectors.
Investing.com  ·  Apr 25, 2026 READ →
NVDA
Trump disclosures show $51M+ invested in bonds in March
Investing.com -- Disclosures released by the US Office of Government Ethics on Saturday reveal that U.S. President Donald Trump carried out a total of 175 transactions in March, purchasing at least $51 million in bonds across several sectors.
Investing.com  ·  Apr 25, 2026 READ →
GS
Trump disclosures show $51M+ invested in bonds in March
Investing.com -- Disclosures released by the US Office of Government Ethics on Saturday reveal that U.S. President Donald Trump carried out a total of 175 transactions in March, purchasing at least $51 million in bonds across several sectors.
Investing.com  ·  Apr 25, 2026 READ →
MSFT
Trump disclosures show $51M+ invested in bonds in March
Investing.com -- Disclosures released by the US Office of Government Ethics on Saturday reveal that U.S. President Donald Trump carried out a total of 175 transactions in March, purchasing at least $51 million in bonds across several sectors.
Investing.com  ·  Apr 25, 2026 READ →
INTC
Tesla Is Down After Its Earnings Report. Time to Buy?
The electric-vehicle company is entering a period of heavy investment, and investors will need some patience.
Motley Fool  ·  Apr 25, 2026 READ →